Korbato Health Announces over JPY45 Million Strategic Seed Round Led by Keio Investment Initiative

Tokyo, Japan - Korbato Health, the pioneer of quality diagnostic AI, today announced the successful completion of an over JPY45 million seed round led by Keio Investment Initiative. The strategic investment also includes funding from five renowned individual investors.

This investment underscores Korbato Health’s quality AI-based product specializing in ECG diagnosis, Korbato Scan. The accuracy of Korbato Scan is assured by an enormous volume of training data of over 15 millions, which, most importantly, were collected across multiple hospitals across the globe, as well as by rigorous expertise in cardiology and machine learning. The contributed capital will fuel Korbato’s continued innovation and expansion within Japan, Asia, and in the wider globe.

"We are thrilled to have the support of such distinguished investors as we continue to contribute to further enhancing accuracy and efficiency of physicians’ diagnosis of cardiovascular diseases. Our mission is to replace low quality AI tools with scientifically proven and genuinely useful products, which enables early detection and prevention of heart diseases.”  - Korbato Health Co-Founder and CEO, Ryuichiro Yagi

About Korbato Health

Korbato Health, the pioneer of quality diagnostic AI, is committed to serve physicians and patients with genuinely practical products, which can early detect and prevent heart diseases. Korbato Health’s truly unique access to enormous volume of backdata and scientifically proven technology open a way to the world without unnecessary deaths due to preventable heart diseases.Learn more at https://korbato-health.com/?lang=en.

Media Contact :　https://korbato-health.com/?page_id=177